Company Filing History:
2 out of 5,448 
1 out of 1 
1 out of 6 Years Active: 2022-2025
Title: Michael Zeisberg: Innovator in Chronic Organ Injury Treatment
Introduction
Michael Zeisberg is a notable inventor based in Goettingen, Germany. He has made significant contributions to the field of medical research, particularly in the prevention and treatment of chronic organ injuries. With a total of 2 patents, his work focuses on innovative therapeutic approaches that aim to improve patient outcomes.
Latest Patents
Zeisberg's latest patents include groundbreaking methods for the prevention or treatment of chronic organ injury. The first patent discloses novel therapeutic approaches aimed at preventing, treating, and delaying the progression of chronic injury and fibrosis in organs. This involves agents that increase homodimer-formation of ARNT, which can be achieved through various means, including inhibitors of protein phosphatase 2A activity and transcriptional repressor complexes. The second patent addresses the treatment of aberrant fibroblast proliferation, utilizing compounds that reduce tyrosine phosphatase activity and other innovative methods to combat diseases related to fibroblast dysfunction.
Career Highlights
Throughout his career, Michael Zeisberg has worked with prestigious institutions such as the University of Texas System and Georg-August-Universität Göttingen. His research has been instrumental in advancing the understanding of organ injuries and their treatments.
Collaborations
Zeisberg has collaborated with esteemed colleagues, including Elisabeth Zeisberg and Gerhard Anton Mueller, contributing to a rich exchange of ideas and research findings in the field.
Conclusion
Michael Zeisberg's innovative work in the treatment of chronic organ injuries showcases his dedication to improving medical therapies. His patents reflect a commitment to advancing healthcare through research and collaboration.